OVID
Ovid Therapeutics Inc.
Latest News for OVID
Wedbush analyst Laura Chico maintained a Buy rating on Ovid Therapeutics today and set a price target of $7.00. Chico covers the Healthcare sector,......
In a report released today, Francois Brisebois from LifeSci Capital maintained a Buy rating on Ovid Therapeutics, with a price target of $5.00. Bri......
In a report released today, Francois Brisebois from LifeSci Capital maintained a Buy rating on Ovid Therapeutics, with a price target of $5.00. Bri......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Knight Therapeutics (KHTRF) and Ovid Therapeutics (O......
In a report released yesterday, Madison Elsaadi from B. Riley Securities reiterated a Buy rating on Ovid Therapeutics, with a price target of $5.00......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OVID | $2.60 | +1.4% | 4.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |